Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

This study has been completed.
Information provided by:
Akros Pharma Inc. Identifier:
First received: May 29, 2008
Last updated: June 2, 2008
Last verified: May 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2006
  Primary Completion Date: December 2004 (Final data collection date for primary outcome measure)